This HTML5 document contains 140 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1093/INFDIS/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q42279944
rdf:type
wikibase:Item
schema:description
мақолаи илмӣ articol științific scientific article published on 31 July 2013 article científic научна статия artigo científico 2013年論文 2013年论文 article scientifique наукова стаття, опублікована в липні 2013 2013年論文 article scientific wetenschappelijk artikel ৩১ জুলাই ২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2013年論文 научни чланак teaduslik artikkel научни чланак 2013年论文 artikulong pang-agham 2013 nî lūn-bûn scientific article published on 31 July 2013 vědecký článek 2013年の論文 vitskapeleg artikkel مقالة علمية نشرت في 31 يوليو 2013 2013年论文 artículo científico publicado en 2013 научная статья artigo científico artículu científicu espublizáu en 2013 vetenskaplig artikel scientific article published on 31 July 2013 tieteellinen artikkeli artikel ilmiah articolo scientifico სამეცნიერო სტატია מאמר מדעי บทความทางวิทยาศาสตร์ 2013年论文 tudományos cikk vitenskapelig artikkel bilimsel makale 2013年論文 2013年论文 գիտական հոդված հրատարակված 2013 թվականի հուլիսի 31-ին artigo científico 2013년 논문 2013年論文 naučni članak videnskabelig artikel scienca artikolo wissenschaftlicher Artikel vedecký článok 2013年论文 artikull shkencor artykuł naukowy επιστημονικό άρθρο bài báo khoa học
p:P577
wds:Q42279944-C037C208-774B-43E8-8DE9-0381C72D1DA7
wdt:P577
2013-07-31T00:00:00Z
p:P407
wds:Q42279944-E1579C0E-CCBE-40C2-AD21-0EB4E96B15C2
wdt:P407
wd:Q1860
p:P2860
wds:Q42279944-0B19F921-8ADE-4645-9C80-56525B54D0BE wds:Q42279944-0F48DE13-5687-4CD2-8A60-2872E29C77B2 wds:Q42279944-110171C1-5B8C-4567-925D-52E5141BB14C wds:Q42279944-26ED39BD-C86B-47FE-B00A-919D7028F7AB wds:Q42279944-2E19DBD1-EE2B-446A-91A6-713FB0B51658 wds:Q42279944-53DC7886-4094-4FC1-800F-4AB0C7C32542 wds:Q42279944-58FABB92-B818-43E5-92B2-DEFE07F9D8D8 wds:Q42279944-60CDE3AB-6F24-4F12-B268-7706F2BE2791 wds:Q42279944-66985F4B-4559-41A9-AE95-4FBA42851B99 wds:Q42279944-68AE5F64-074F-48D1-AD5B-1AC7C813E342 wds:Q42279944-8DBD5226-2236-4FE9-8FE2-3E0BABC56C7C wds:Q42279944-923F8F59-29E0-4135-ABE6-4856DB9F5F70 wds:Q42279944-93034BB8-DC6F-4808-8A55-877EBA6A03D3 wds:Q42279944-B3D631A1-81A0-4E17-99AE-1CDE75A07A39 wds:Q42279944-BC26CDA3-0F55-41C7-A443-0BE0E4DB591A wds:Q42279944-CA6D4147-9581-4531-AC88-AEAA7271937D
wdt:P2860
wd:Q45359726 wd:Q35842681 wd:Q37900039 wd:Q39998958 wd:Q37191759 wd:Q37867102 wd:Q37461377 wd:Q34635527 wd:Q34079162 wd:Q33585349 wd:Q35094040 wd:Q33585318 wd:Q28254168 wd:Q36168232 wd:Q49157618 wd:Q33562824
p:P2093
wds:Q42279944-80F00AC4-33BC-4BE0-8411-58E9BFF85651 wds:Q42279944-314D2913-09A9-4DCA-A587-E8C31DF8520A wds:Q42279944-A6793B88-FEBD-4636-9E69-A3D47FC22361 wds:Q42279944-B0CFE43F-3048-4333-B4AE-F7FE6E44E4AF wds:Q42279944-6A23AED4-0C8E-49E5-97D2-1066D736066D wds:Q42279944-6CCBB28C-ECF2-474E-8B66-3B5C4A33823F
wdt:P2093
Edouard Ledent Maria Luisa Rodriguez de la Pinta Harry Collins Johann F Mols Thomas C Heineman Roman Chlibek
rdfs:label
Safety and immunogenicity of an AS01-adjuvanted varicella-zoster virus subunit candidate vaccine against herpes zoster in adults >=50 years of age. Safety and immunogenicity of an AS01-adjuvanted varicella-zoster virus subunit candidate vaccine against herpes zoster in adults >=50 years of age.
skos:prefLabel
Safety and immunogenicity of an AS01-adjuvanted varicella-zoster virus subunit candidate vaccine against herpes zoster in adults >=50 years of age. Safety and immunogenicity of an AS01-adjuvanted varicella-zoster virus subunit candidate vaccine against herpes zoster in adults >=50 years of age.
schema:name
Safety and immunogenicity of an AS01-adjuvanted varicella-zoster virus subunit candidate vaccine against herpes zoster in adults >=50 years of age. Safety and immunogenicity of an AS01-adjuvanted varicella-zoster virus subunit candidate vaccine against herpes zoster in adults >=50 years of age.
p:P50
wds:Q42279944-0BF6C7C3-8330-41B5-BC8A-0A081F8ACA48
wdt:P50
wd:Q124363728
p:P1476
wds:Q42279944-5278E5B0-6D57-45C2-B9EB-E7A7A574AE45
wdt:P1476
Safety and immunogenicity of an AS01-adjuvanted varicella-zoster virus subunit candidate vaccine against herpes zoster in adults >=50 years of age.
p:P304
wds:Q42279944-83A6BA05-74E7-4853-85DC-5B4EAC1CE8C4
wdt:P304
1953-1961
p:P31
wds:Q42279944-75CD525A-6CAF-4D29-8E9C-23430E7478D8
wdt:P31
wd:Q13442814
p:P921
wds:Q42279944-D6F79A2B-03A2-46B5-A4FA-7C5C74FF7972
wdt:P921
wd:Q182155
p:P698
wds:Q42279944-9C237AC2-7006-4348-BB41-7AA7ED0F9264
wdtn:P698
n10:23904292
wdt:P698
23904292
p:P1433
wds:Q42279944-EFCAB1A8-D133-43B7-AB04-79DF5F49BC55
wdt:P1433
wd:Q4051141
p:P433
wds:Q42279944-9CAC3FAF-E540-4DBE-A4A9-F694EBAE5557
p:P478
wds:Q42279944-E9686454-E91B-447C-AF59-9B61979F626E
wdt:P433
12
wdt:P478
208
p:P1104
wds:Q42279944-014D0BFA-EDD1-4257-B8CF-9021A9EDAA24
wdt:P1104
9
p:P356
wds:Q42279944-B9C2301E-9F18-45D9-81B3-38C4D3EFD5C4
wdtn:P356
n11:JIT365
wdt:P356
10.1093/INFDIS/JIT365
p:P5875
wds:Q42279944-C47D4628-7991-4451-A210-17CA003E431F
wdt:P5875
254261726